← Back
$JANX All transactions

Janux Therapeutics, Inc.

A

$ Value

$0

Shares

31,400

Price

$0

Filed

Jan 2

Insider

Name

DiRaimondo Thomas

Title

Chief Scientific Officer

CIK

0002005618

Roles

Officer

Transaction Details

Transaction Date

2026-01-02

Code

A

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

155,825

Footnotes

The shares were automatically sold to cover tax withholding obligations associated with the vesting of restricted stock units. | Includes 4,049 shares acquired under the Issuer's 2021 Employee Stock Purchase Plan (the "Plan") on May 15, 2025. Also, on January 3, 2025, the Reporting Person filed a Form 4 which inadvertently reported an aggregate of 7,781 shares acquired under the Plan. In fact, 5,432 of the shares were already reported as acquired by the Reporting Person under the Plan on a Form 3 filed on January 3, 2024 and 1,406 of the shares were reported as acquired by the Reporting Person under the Plan on a Form 4 filed on September 27, 2024. | Represents the grant of restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of the Issuer's common stock. The RSUs vest in four equal annual installments beginning on January 1, 2027. | 25% of the shares subject to the option vest on January 1, 2027 and the balance will vest in equal monthly installments thereafter over a three year period.

Filing Info

Accession No.

0002005618-26-000002

Form Type

4

Issuer CIK

0001817713

DiRaimondo Thomas's History

Date Ticker Type Value
2026-01-02 JANX $34K
2026-01-02 JANX A $0
2026-01-02 JANX A $0

Other Insiders at JANX (90d)

Insider Bought Sold Last
Go William
Chief Medical Officer
2026-02-02